BIOS Fund I, LP

13D and 13G Filings

13D/G filings
13D on 1 security, 13G on 1 security
Location
Fort Worth, TX
CIK
0001697316
Form D filings
1 filing
All SEC filings
View on sec.gov
Issuer % of Class Filed
Rein Therapeutics, Inc. 13G/A Amendment 2
RNTX · 00887A204
10.0% 5/8/2026
Event 5/6/2026
Actuate Therapeutics, Inc. 13D/A Amendment 2
ACTU · 005083100
49.8% 6/30/2025
Event 6/27/2025
Actuate Therapeutics, Inc. 13D/A Amendment 1
ACTU · 005083100
51.3% 5/27/2025
Event 5/22/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.